Sarepta Therapeutics Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
A description of the facilities we own and/or occupy is included in the following table. We believe that our current facilities in Cambridge, Andover, Burlington and Bedford, Massachusetts, Dublin and Columbus, Ohio and Durham, North Carolina are suitable and will provide sufficient capacity to meet the projected needs of our business for the next 12 months. Except as noted below, all of our properties are currently being used in the operation of our business.
| Location of Property | SquareFootage | Lease ExpirationDate | Purpose | Other Information |
|---|---|---|---|---|
| 215 First Street, Cambridge, MA | 149,589 | September 2025 | Laboratory and office space | Corporate headquarters |
| 600 Federal Street, Andover, MA | 11,832 | December 2026 | Laboratory and office space | Laboratory and office space |
| 100 Federal Street, Andover, MA | 65,589 | N/A- facility is owned | Laboratory and office space | Primarily laboratory space |
| 300 Federal Street, Andover, MA | 23,102 | December 2024 | Office space | Office space |
| 55 Network Drive, Burlington, MA | 44,740 | December 2024 | Laboratory and office space | Primarily laboratory space |
| 50-52 Crosby Drive, Bedford, MA | 288,000 | January 2038 | Laboratory and office space | Primarily laboratory space |
| 5200 Blazer Parkway, Dublin, OH 3rd Floor | 22,600 | October 2024 | Laboratory and office space | Primarily laboratory space |
| 3435 Stelzer Road, Columbus, OH | 151,661 | December 2036 | Laboratory and office space | Primarily laboratory space |
| 701 West Main Street, Suite 102, Durham, NC | 4,346 | March 2025 | Laboratory and office space | Primarily laboratory space |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.